These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18356545)

  • 1. Is the use of hypertonic mannitol appropriate in the management of intracerebral hemorrhage?
    Prakash ES
    Stroke; 2008 May; 39(5):e85; author reply e86-7. PubMed ID: 18356545
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacodynamics and pharmacokinetics of therapeutic osmoregulating agents in increased intracranial pressure].
    Prange HW; Nau R
    Zentralbl Neurochir; 1997; 58(3):127-33. PubMed ID: 9446463
    [No Abstract]   [Full Text] [Related]  

  • 3. Passage of mannitol into the brain around gliomas: a potential cause of rebound phenomenon. A study on 21 patients.
    Palma L; Bruni G; Fiaschi AI; Mariottini A
    J Neurosurg Sci; 2006 Sep; 50(3):63-6. PubMed ID: 17019386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline.
    Qureshi AI; Wilson DA; Traystman RJ
    Neurosurgery; 1999 May; 44(5):1055-63; discussion 1063-4. PubMed ID: 10232539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of osmotherapy in intracerebral hemorrhage.
    Kalita J; Ranjan P; Misra UK
    Neurol India; 2003 Mar; 51(1):104-9. PubMed ID: 12865537
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperosmolar therapy for raised intracranial pressure.
    Ropper AH
    N Engl J Med; 2012 Aug; 367(8):746-52. PubMed ID: 22913684
    [No Abstract]   [Full Text] [Related]  

  • 7. Is mannitol safe for patients with intracerebral hemorrhages? Renal considerations.
    Dziedzic T; Szczudlik A; Klimkowicz A; Rog TM; Slowik A
    Clin Neurol Neurosurg; 2003 Apr; 105(2):87-9. PubMed ID: 12691796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of transtentorial herniation with hypertonic saline.
    Koenig MA; Bryan M; Lewin JL; Mirski MA; Geocadin RG; Stevens RD
    Neurology; 2008 Mar; 70(13):1023-9. PubMed ID: 18272864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging the gold standard: should mannitol remain our first-line defense against intracranial hypertension?
    Infanti JL
    J Neurosci Nurs; 2008 Dec; 40(6):362-8. PubMed ID: 19170304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osmotherapy. Basic concepts and controversies.
    Paczynski RP
    Crit Care Clin; 1997 Jan; 13(1):105-29. PubMed ID: 9012578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical treatment of intracerebral hemorrhage.
    Sacco S; Marini C; Carolei A
    Neurol Sci; 2004 Mar; 25 Suppl 1():S6-9. PubMed ID: 15045610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osmotic therapy: fact and fiction.
    Diringer MN; Zazulia AR
    Neurocrit Care; 2004; 1(2):219-33. PubMed ID: 16174920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salt or sugar for your injured brain? A meta-analysis of randomised controlled trials of mannitol versus hypertonic sodium solutions to manage raised intracranial pressure in traumatic brain injury.
    Rickard AC; Smith JE; Newell P; Bailey A; Kehoe A; Mann C
    Emerg Med J; 2014 Aug; 31(8):679-83. PubMed ID: 23811861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mannitol and hypertonic saline: going head to head.
    Härtl R; Froelich M
    Crit Care Med; 2008 Mar; 36(3):1005-6. PubMed ID: 18431303
    [No Abstract]   [Full Text] [Related]  

  • 15. Treating intracranial hypertension: time to abandon mannitol?
    Pettilä V; Cooper DJ
    Crit Care Resusc; 2009 Jun; 11(2):94-5. PubMed ID: 19485871
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypertonic saline solutions for treatment of intracranial hypertension.
    Himmelseher S
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):414-26. PubMed ID: 17873594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRO: osmotherapy for the treatment of acute intracranial hypertension.
    Grape S; Ravussin P
    J Neurosurg Anesthesiol; 2012 Oct; 24(4):402-6. PubMed ID: 22955194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mannitol or hypertonic saline for intracranial hypertension? A point of view.
    Castillo LB; Bugedo GA; Paranhos JL
    Crit Care Resusc; 2009 Jun; 11(2):151-4. PubMed ID: 19485880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and safety of glycerol versus mannitol in patients with cerebral oedema and elevated intracranial pressure: A systematic review and meta-analysis.
    Wang J; Ren Y; Wang SF; Kan LD; Zhou LJ; Fang HM; Fan H
    J Clin Pharm Ther; 2021 Apr; 46(2):504-514. PubMed ID: 33217016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertonic saline for craniotomy?
    McDonagh DL; Warner DS
    Anesthesiology; 2007 Nov; 107(5):689-91. PubMed ID: 18073540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.